Patients Views & Analysis

Views & Analysis

Ipsen’s John Chaddock on making neurotoxins a priority for h...

Injected neurotoxins can be incredibly potent in treating spasticity from neurological diseases, but the field doesn’t always get the attention it needs. Ipsen’s John Chaddock tells u

Views & Analysis

Why we need the human element of remote clinical trials

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives.

Views & Analysis

Patients as Partners Europe: Are we doing patient centricity...

To be truly patient centric, do we need to turn the current model on its head and work within a more free-thinking, free-speaking framework?

Views & Analysis

Patient partnerships: putting relevance into relationships

There are perhaps two ways to look at 2020 – on the surface, it has been a year of pandemic health catastrophe, on a deeper level it has been a year where we finally acknowledged the fragil

Views & Analysis

Assessing physician practices and expectations in the post-C...

The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions.

Views & Analysis

3 practical steps for improving patient support

Research Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to make their patient support programmes as powerful as possible.

Ipsen’s John Chaddock on making neurotoxins a priority for h...

Why we need the human element of remote clinical trials

Patients as Partners Europe: Are we doing patient centricity...

Patient partnerships: putting relevance into relationships

Assessing physician practices and expectations in the post-C...

3 practical steps for improving patient support

Aspen, Bambusa close IPOs as Corxel takes SPAC route

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks